Company page
Immutep Ltd
Immutep Ltd (Ticker: IMM) is a public company based in Australia, with a market capitalization of approximately AUD 50.6 million. The company focuses on developing innovative immunotherapy treatments for cancer and autoimmune diseases. Immutep is dedicated to advancing its research and clinical programs to provide effective therapeutic options.
- Ticker
- IMM:ASX
- Asset type
- Stock
- Market cap
- $50.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD